Wall Street Experts
ver. ZuMIgo(08/25)
Prognozy (mln) dla Boston Scientific Corporation
Okres |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
Przychód (średnia) |
19,499.94 |
21,588.70 |
23,752.46 |
25,861.57 |
27,917.75 |
Przychód Δ r/r |
0.00% |
10.71% |
10.02% |
8.88% |
7.95% |
Przychód (min) |
19,109.11 |
21,089.54 |
23,693.68 |
25,131.42 |
27,129.55 |
Przychód (max) |
19,643.92 |
22,160.65 |
23,811.25 |
26,484.14 |
28,589.82 |
EBITDA (średnia) |
4,126.66 |
4,568.69 |
5,026.60 |
5,472.94 |
5,908.07 |
EBIT (średnia) |
2,354.25 |
2,606.43 |
2,867.66 |
3,122.30 |
3,370.54 |
EBIT % |
12.07% |
12.07% |
12.07% |
12.07% |
12.07% |
Zysk netto (średni) |
4,338.22 |
4,859.52 |
4,000.75 |
6,198.21 |
6,779.42 |
Zysk netto % |
22.25% |
22.51% |
16.84% |
23.97% |
24.28% |
EPS (średnia) |
2.92 |
3.30 |
3.72 |
4.17 |
4.56 |
Liczba analityków (Przychody) |
18 |
24 |
25 |
11 |
12 |
Liczba analityków (EPS) |
21 |
18 |
12 |
7 |
10 |
symbol |
BSX |
BSX |
BSX |
BSX |
BSX |